[go: up one dir, main page]

FI900017L - Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi - Google Patents

Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi Download PDF

Info

Publication number
FI900017L
FI900017L FI900017A FI900017A FI900017L FI 900017 L FI900017 L FI 900017L FI 900017 A FI900017 A FI 900017A FI 900017 A FI900017 A FI 900017A FI 900017 L FI900017 L FI 900017L
Authority
FI
Finland
Prior art keywords
active ingredient
controlled release
low dose
aspirin tablets
preparing aspirin
Prior art date
Application number
FI900017A
Other languages
English (en)
Swedish (sv)
Other versions
FI95776C (fi
FI900017A0 (fi
FI95776B (fi
Inventor
Steven Edgar Frisbee
William Neil Charman
Garret Adare Fitzgerald
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of FI900017A0 publication Critical patent/FI900017A0/fi
Publication of FI900017L publication Critical patent/FI900017L/fi
Application granted granted Critical
Publication of FI95776B publication Critical patent/FI95776B/fi
Publication of FI95776C publication Critical patent/FI95776C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI900017A 1989-01-03 1990-01-03 Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi FI95776C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US29383289 1989-01-03
US42662089A 1989-10-24 1989-10-24
US42662089 1989-10-24

Publications (4)

Publication Number Publication Date
FI900017A0 FI900017A0 (fi) 1990-01-03
FI900017L true FI900017L (fi) 1990-07-04
FI95776B FI95776B (fi) 1995-12-15
FI95776C FI95776C (fi) 1996-03-25

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900017A FI95776C (fi) 1989-01-03 1990-01-03 Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi

Country Status (20)

Country Link
EP (1) EP0377439B1 (fi)
JP (1) JP2966871B2 (fi)
KR (1) KR0151590B1 (fi)
AR (1) AR244548A1 (fi)
AT (1) ATE127690T1 (fi)
AU (1) AU622254B2 (fi)
CA (1) CA2006975C (fi)
DE (1) DE69022251T2 (fi)
DK (1) DK0377439T3 (fi)
ES (1) ES2076975T3 (fi)
FI (1) FI95776C (fi)
GR (1) GR3017576T3 (fi)
HK (1) HK35396A (fi)
IE (1) IE69270B1 (fi)
IL (1) IL92854A (fi)
MX (1) MX174376B (fi)
MY (1) MY104871A (fi)
NO (1) NO177127C (fi)
NZ (1) NZ231954A (fi)
PT (1) PT92780B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
BR9810027A (pt) * 1997-06-11 2000-09-12 Procter & Gamble Comprimido revestido por pelìcula para melhorada segurança do trato gastrintestinal superior
KR20070093988A (ko) * 2005-01-06 2007-09-19 씨브이 쎄러퓨틱스, 인코포레이티드 라놀라진 함유 서방성 약제학적 제형물
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
WO2017062027A1 (en) * 2015-10-09 2017-04-13 Bayer Healthcare Llc Modified release formulation of naproxen sodium
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264867D1 (en) * 1981-04-27 1985-08-29 Haessle Ab New pharmaceutical preparation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
FI95776C (fi) 1996-03-25
DK0377439T3 (da) 1995-10-30
PT92780B (pt) 1997-12-31
ES2076975T3 (es) 1995-11-16
AU4719489A (en) 1990-07-12
GR3017576T3 (en) 1995-12-31
EP0377439A2 (en) 1990-07-11
KR900011453A (ko) 1990-08-01
DE69022251D1 (de) 1995-10-19
FI900017A0 (fi) 1990-01-03
HK35396A (en) 1996-03-08
IE69270B1 (en) 1996-08-21
AR244548A1 (es) 1993-11-30
ATE127690T1 (de) 1995-09-15
NO900009D0 (no) 1990-01-02
NO900009L (no) 1990-07-04
EP0377439A3 (en) 1991-02-06
CA2006975A1 (en) 1990-07-03
MX18883A (es) 1993-09-01
IL92854A0 (en) 1990-09-17
MX174376B (es) 1994-05-11
NO177127B (no) 1995-04-18
EP0377439B1 (en) 1995-09-13
AU622254B2 (en) 1992-04-02
DE69022251T2 (de) 1996-05-02
FI95776B (fi) 1995-12-15
IL92854A (en) 1994-11-28
NZ231954A (en) 1991-12-23
JPH02262520A (ja) 1990-10-25
JP2966871B2 (ja) 1999-10-25
KR0151590B1 (ko) 1998-10-15
CA2006975C (en) 2000-04-04
IE894120L (en) 1990-07-03
MY104871A (en) 1994-06-30
NO177127C (no) 1995-07-26
PT92780A (pt) 1990-07-31

Similar Documents

Publication Publication Date Title
FI930657A7 (fi) Menetelmä pidennetyn aktiiviaineluovutuksen omaavien annosmuotojen valmistamiseksi
FI885101L (fi) Menetelmä lääkettä säännöstellysti vapauttavan annostusmuodon valmistamiseksi
HUT47843A (en) Process for producing pharmaceutical with regulated active ingredient release
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
FI921104A7 (fi) Istutettava vapautuslääkkeenjakaja
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
HUT45186A (en) Insecticides comprising heterocyclic compounds as active ingredient and process for producing the active ingredient
ZA894020B (en) Controlled release pharmaceutical formulation
IL70071A (en) Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
GB2187643B (en) Method for the preparation of tablets slowly releasing the active principle
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
DK256290A (da) Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling
GB2226804B (en) Process for preparing microcapsules providing the rapid release of a drug as active ingredient
NO173239C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
FI913409L (fi) Menetelmä vaikuttavana aineena mesnaa sisältävien tablettien ja granulaatin valmistamiseksi
FI900017L (fi) Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
FI891069A7 (fi) Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: STERLING WINTHROP INC.

BB Publication of examined application
FG Patent granted

Owner name: STERLING WINTHROP INC.